Urban Wealth Management’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Urban Wealth Management’s Portfolio BIOR Stock Details BIOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1K	Buy	+4	New	+$843	﹤0.01%	338

Other funds holding BIOR

ACM

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Urban Wealth Management's BIOR Position: Q2 2022 in Review

Urban Wealth Management opened a new position in Biora Therapeutics, Inc. Common Stock (BIOR) in Q2 2022: 4 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #338 among its holdings.

46 funds tracked by Wall St. Rank hold BIOR as of Q2 2022.

Urban Wealth Management held 4 shares of Biora Therapeutics, Inc. Common Stock worth $1K as of Q2 2022.
Biora Therapeutics, Inc. Common Stock was a new Urban Wealth Management position in Q2 2022.
Biora Therapeutics, Inc. Common Stock made up ﹤0.01% of Urban Wealth Management's portfolio in Q2 2022, its #338 holding.
46 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Urban Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.